Neola Medical AB Total Liabilities
Neola Medical AB total liabilities. Based on the latest financial reports, Neola Medical AB (NEOLA) has total liabilities worth Skr6.86 Million SEK (≈ $737.82K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See NEOLA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Neola Medical AB (2018–2025)
Total liabilities of Neola Medical AB from 2018 to 2025. This chart illustrates how Neola Medical AB's total liabilities have evolved over time, based on quarterly financial data.
Neola Medical AB Competitors by Total Liabilities
The table below lists competitors of Neola Medical AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NanoVibronix Inc
NASDAQ:NAOV
|
USA | $11.92 Million |
|
Pure Biologics Spólka Akcyjna
WAR:PUR
|
Poland | zł20.72 Million |
|
CPPGroup Plc
F:4CV1
|
Germany | €22.06 Million |
|
AHT Syngas Technology NV
F:3SQ1
|
Germany | €6.14 Million |
|
IDOX plc
LSE:IDOX
|
UK | GBX71.48 Million |
|
One SA
WAR:FMG
|
Poland | zł47.35 Million |
|
SINTEZA S.A.
RO:STZ
|
Romania | RON13.16 Million |
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
USA | $5.60 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Neola Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NEOLA current and non-current assets.
Liquidity & Leverage Metrics
Neola Medical AB Total Liabilities Ratios Explained
Neola Medical AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neola Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neola Medical AB (2018–2025)
The table below shows the annual total liabilities of Neola Medical AB from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr3.00 Million ≈ $322.74K |
-35.49% |
| 2024-12-31 | Skr4.65 Million ≈ $500.31K |
-33.49% |
| 2023-12-31 | Skr6.99 Million ≈ $752.24K |
-10.90% |
| 2022-12-31 | Skr7.84 Million ≈ $844.25K |
+145.62% |
| 2021-12-31 | Skr3.19 Million ≈ $343.73K |
+31.98% |
| 2020-12-31 | Skr2.42 Million ≈ $260.43K |
+61.12% |
| 2019-12-31 | Skr1.50 Million ≈ $161.64K |
+123.85% |
| 2018-12-31 | Skr671.00K ≈ $72.21K |
-- |
About Neola Medical AB
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume chan… Read more